Zhaofeng Pan

591 total citations · 1 hit paper
16 papers, 402 citations indexed

About

Zhaofeng Pan is a scholar working on Molecular Biology, Rheumatology and Orthopedics and Sports Medicine. According to data from OpenAlex, Zhaofeng Pan has authored 16 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Rheumatology and 4 papers in Orthopedics and Sports Medicine. Recurrent topics in Zhaofeng Pan's work include Bone Metabolism and Diseases (6 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Inflammasome and immune disorders (3 papers). Zhaofeng Pan is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Inflammasome and immune disorders (3 papers). Zhaofeng Pan collaborates with scholars based in China, Switzerland and United Kingdom. Zhaofeng Pan's co-authors include Haibin Wang, Junzheng Yang, Jiacong Xiao, Shaocong Li, Peng Chen, Gangyu Zhang, Bai‐Hao Chen, Qi He, Zihao Wang and Jiaxu Zeng and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Zhaofeng Pan

16 papers receiving 400 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis

2022 149 citations Qi He, Junzheng Yang et al. Biomedicine & Pharmacotherapy profile →

Peers

Zhaofeng Pan

RHEUM

PRM

PHARM

Jiacong Xiao China

Qi He China

Nianhu Li China

Mingzhi Gong China

Zhuangzhuang Jin China

Xiaofei Feng China

Jingting Xu China

Naiqiang Zhu China

Shengyu Cui China

Jiacong Xiao China

Zhaofeng Pan

242 ×0.9

122 ×1.0

95 ×1.0

RHEUM

83 ×1.0

PRM

42 ×0.9

PHARM

Citations per year, relative to Zhaofeng Pan Zhaofeng Pan (= 1×) peers Jiacong Xiao

Countries citing papers authored by Zhaofeng Pan

Since Specialization

Citations

This map shows the geographic impact of Zhaofeng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaofeng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaofeng Pan more than expected).

Fields of papers citing papers by Zhaofeng Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaofeng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaofeng Pan. The network helps show where Zhaofeng Pan may publish in the future.

Co-authorship network of co-authors of Zhaofeng Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaofeng Pan. A scholar is included among the top collaborators of Zhaofeng Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaofeng Pan. Zhaofeng Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yang, Junzheng, Delong Chen, Qi He, et al.. (2024). Arctiin alleviates knee osteoarthritis by suppressing chondrocyte oxidative stress induced by accumulated iron via AKT/NRF2/HO-1 signaling pathway. Scientific Reports. 14(1). 31935–31935. 4 indexed citations

Xiao, Jiacong, Qi He, Zhaofeng Pan, et al.. (2024). Picroside II suppresses chondrocyte pyroptosis through MAPK/NF-κB/NLRP3 signaling pathway alleviates osteoarthritis. PLoS ONE. 19(8). e0308731–e0308731. 4 indexed citations

Li, Miao, Jiacong Xiao, Bai‐Hao Chen, et al.. (2024). Loganin inhibits the ROS-NLRP3-IL-1β axis by activating the NRF2/HO-1 pathway against osteoarthritis. Chinese Journal of Natural Medicines. 22(11). 977–990. 1 indexed citations

Chen, Chuyi, Bohao Chen, Qi He, et al.. (2024). Cardamonin attenuates iron overload-induced osteoblast oxidative stress through the HIF-1α/ROS pathway. International Immunopharmacology. 142(Pt A). 112893–112893. 8 indexed citations

He, Qi, Junzheng Yang, Weijian Chen, et al.. (2024). Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation. BMC Complementary Medicine and Therapies. 24(1). 24–24. 6 indexed citations

Li, Shaocong, Qi He, Bai‐Hao Chen, et al.. (2023). Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway. Scientific Reports. 13(1). 13744–13744. 18 indexed citations

Chen, Bohao, Qi He, Chuyi Chen, et al.. (2023). Combination of curcumin and catalase protects against chondrocyte injury and knee osteoarthritis progression by suppressing oxidative stress. Biomedicine & Pharmacotherapy. 168. 115751–115751. 29 indexed citations

Xiao, Jiacong, Gangyu Zhang, Bohao Chen, et al.. (2023). Quercetin protects against iron overload-induced osteoporosis through activating the Nrf2/HO-1 pathway. Life Sciences. 322. 121326–121326. 38 indexed citations

He, Qi, Dawei Gong, Jiacong Xiao, et al.. (2023). Myricitrin promotes osteogenesis and prevents ovariectomy bone mass loss via the PI3K/AKT signalling pathway. Journal of Cellular Biochemistry. 124(8). 1155–1172. 4 indexed citations

10.

Li, Miao, Zhaofeng Pan, Qi He, et al.. (2023). Arctiin attenuates iron overload‑induced osteoporosis by regulating the PI3K/Akt pathway. International Journal of Molecular Medicine. 52(5). 6 indexed citations

11.

Chen, Bohao, Qi He, Junzheng Yang, et al.. (2022). Metformin suppresses Oxidative Stress induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis. Life Sciences. 312. 121092–121092. 36 indexed citations

12.

Xiao, Jiacong, Gangyu Zhang, Qi He, et al.. (2022). Bioinformatics analysis combined with experimental validation to explore the mechanism of XianLing GuBao capsule against osteoarthritis. Journal of Ethnopharmacology. 294. 115292–115292. 14 indexed citations

13.

Pan, Zhaofeng, Qi He, Jiaxu Zeng, et al.. (2022). Naringenin protects against iron overload-induced osteoarthritis by suppressing oxidative stress. Phytomedicine. 105. 154330–154330. 53 indexed citations

14.

He, Qi, Junzheng Yang, Zhaofeng Pan, et al.. (2022). Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis. Biomedicine & Pharmacotherapy. 157. 113915–113915. 149 indexed citations breakdown →

15.

Yang, Junzheng, Qi He, Yunhan Wang, et al.. (2021). Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array. Phytomedicine. 94. 153810–153810. 17 indexed citations

16.

He, Qi, Junzheng Yang, Gangyu Zhang, et al.. (2021). Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validation. Journal of Ethnopharmacology. 273. 113946–113946. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact